Top-News

Schnelle Produktionsaufnahme: Multi-Tenbagger-Potenzial direkt in Spanien?(Anzeige)

Ein Arzt berät einen Patienten (Symbolbild).

Dienstag, 02.08.2016 13:05 von PR Newswire | Aufrufe: 92

Cardinal Health Reports Q4 And Fiscal 2016 Results, Provides Fiscal 2017 Outlook

Ein Arzt berät einen Patienten (Symbolbild). © TommL / Vetta / Getty Images https://www.gettyimages.de/

PR Newswire

DUBLIN, Ohio, Aug. 2, 2016

DUBLIN, Ohio, Aug. 2, 2016 /PRNewswire/ -- Cardinal Health today reported fourth-quarter fiscal year 2016 revenues of $31.4 billion, an increase of 14 percent from the fourth quarter last year, and fiscal 2016 revenues of $121.5 billion, an increase of 19 percent from the same period last year.

For the quarter, the company reported growth in GAAP operating earnings of 11 percent to $620 million and in non-GAAP operating earnings of 5 percent to $643 million. GAAP operating earnings for fiscal year 2016 were $2.5 billion, an increase of 14 percent, and non-GAAP operating earnings for the fiscal year were $2.9 billion, an increase of 17 percent from the prior fiscal year.

For the quarter, GAAP diluted earnings per share from continuing operations² (EPS) increased 16 percent to $1.02, while non-GAAP diluted EPS increased 14 percent to $1.14. GAAP diluted EPS for fiscal year 2016 increased 20 percent to $4.32, and non-GAAP diluted EPS increased 20 percent to $5.24.

"We finished fiscal 2016 having generated the highest revenues, the largest GAAP and non-GAAP operating earnings, and the greatest operating cash flow in our company's history. Our teams worked incredibly hard this past year while never losing sight of the ultimate goal – serving patients and their families," said George Barrett, chairman and CEO of Cardinal Health, Inc. "The Cardinal Health team is well-positioned to adapt, innovate and lead during a time of great change in the healthcare industry."

Q4 and Fiscal Year Summary

Q4 FY16

ARIVA.DE Börsen-Geflüster

Kurse

Cardinal Health

98,91 $

-3,95%

Q4 FY15

Y/Y

FY16

FY15

Y/Y

Revenue

$31.4 billion

$27.5 billion

14%

$121.5 billion

$102.5 billion

19%

GAAP Operating Earnings

$620 million

$558 million

11%

$2,459 million

$2,161million

14%

Non-GAAP Operating Earnings

$643 million

$611 million

$2,895 million

$2,472 million

17%

GAAP Earnings from Continuing Operations²

$333 million

$293 million

14%

$1,427 million

$1,212 million

18%

Non-GAAP Earnings from Continuing Operations²

$372 million

$333 million

12%

$1,732 million

$1,469 million

18%

GAAP Diluted EPS from Continuing Operations²

$1.02

$0.88

16%

$4.32

$3.61

20%

Non-GAAP Diluted EPS from Continuing Operations²

$1.14

$1.00

14%

$5.24

$4.38

20%

SEGMENT RESULTS

Pharmaceutical Segment

Fourth-quarter revenue for the Pharmaceutical segment increased 14 percent to $28.2 billion due to growth from existing and net new Pharmaceutical Distribution customers and, to a lesser extent, performance from the Specialty business. Segment profit for the quarter increased 1 percent to $542 million due to contributions from acquisitions, largely offset by the loss of a large customer contract, which expired on March 31, 2016.

For the full year, revenue for the Pharmaceutical segment increased 20 percent to $109.1 billion, and segment profit increased 19 percent to $2.5 billion.

	Q4 FY16	Q4 FY15	Y/Y	FY16	FY15	Y/Y
Revenue	$28.2 billion	$24.7 billion	14%	$109.1 billion	$91.1 billion	20%
Segment Profit	$542 million	$535 million	1%	$2.5 billion	$2.1 billion	19%

Medical Segment

Fourth-quarter revenue for the Medical segment increased 12 percent to $3.2 billion primarily due to contributions from acquisitions, and, to a lesser extent, growth from Cardinal Health Brand products. Segment profit increased 19 percent to $122 million due to contributions from acquisitions and Cardinal Health Brand products.

Full-year revenue for the Medical segment increased 9 percent to $12.4 billion, and segment profit increased 6 percent to $457 million.

Q4 FY16

Q4 FY15

Y/Y

FY16

FY15

Y/Y

Mehr Nachrichten zur Cardinal Health Aktie kostenlos abonnieren

E-Mail-Adresse

Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.